It has come to our attention that we made two errors in preparation of this
manuscript. First, in the STAR Methods, under the subheading of “Hypermutators
and Immune Infiltrates” within the “Quantification and Statistical
Analysis” section, we inadvertently referred to Figures S7A-S7C for data
corresponding to sample stratification by hypermutator status alone in the last
sentence. It should have referred to Figure S6A-S6C. Second, the lists of highly
frequent missense mutations for COAD (colon adenocarcinoma) and READ (rectum
adenocarcinoma) displayed in Figure S7 were
incorrect because when we ordered the mutations in the initial analysis, we mistakenly
combined the two cancer types COAD and READ for analysis, despite the fact that they
were listed as two separate cancer types in the x-axis of the figure. After re-ordering
the mutations by frequency for COAD and READ independently, information on highly
frequent missense mutations for each of these cancer types is different and updated now
in the revised Figure S7. These errors don’t
change the major conclusions of the paper and have been corrected online. We apologize
for any confusion they may have caused.
Figure S7.
On-Label/Off-Label Calculations for Druggable Mutations in Cancer
(original)
Figure S7.
On-Label/Off-Label Calculations for Druggable Mutations in Cancer
(corrected)
Authors: Nallely Ramos-Betancourt; Matthew G Field; Jesus H Davila-Alquisiras; Carol L Karp; Luis F Hernández-Zimbrón; Roberto García-Vázquez; Kristian A Vazquez-Romo; Gaofeng Wang; Jans Fromow-Guerra; Everardo Hernandez-Quintela; Anat Galor Journal: Ocul Surf Date: 2020-07-24 Impact factor: 5.033
Authors: Joseph H McAbee; Barbara H Rath; Kristin Valdez; Dejauwne L Young; Xiaolin Wu; Uma T Shankavaram; Kevin Camphausen; Philip J Tofilon Journal: Cancer Res Date: 2019-10-15 Impact factor: 12.701
Authors: Siyuan Zheng; Kristin Alfaro-Munoz; Wei Wei; Xiaojing Wang; Fang Wang; Agda Karina Eterovic; Kenna R Mills Shaw; Funda Meric-Bernstam; Gregory N Fuller; Ken Chen; Roel G Verhaak; Gordon B Mills; W K Alfred Yung; Shiao-Pei Weathers; John F de Groot Journal: Mol Cancer Ther Date: 2019-03-29 Impact factor: 6.261
Authors: Pedram Razavi; Jared L Johnson; Hong Shao; Neil Vasan; Hardik Shah; Alesia Antoine; Erik Ladewig; Alexander Gorelick; Ting-Yu Lin; Eneda Toska; Guotai Xu; Abiha Kazmi; Matthew T Chang; Barry S Taylor; Maura N Dickler; Komal Jhaveri; Sarat Chandarlapaty; Raul Rabadan; Ed Reznik; Melissa L Smith; Robert Sebra; Frauke Schimmoller; Timothy R Wilson; Lori S Friedman; Lewis C Cantley; Maurizio Scaltriti; José Baselga Journal: Science Date: 2019-11-08 Impact factor: 47.728
Authors: Cathy B Moelans; Joep de Ligt; Petra van der Groep; Pjotr Prins; Nicolle J M Besselink; Marlous Hoogstraat; Natalie D Ter Hoeve; Miangela M Lacle; Robert Kornegoor; Carmen C van der Pol; Wendy W J de Leng; Ellis Barbé; Bert van der Vegt; John Martens; Peter Bult; Vincent T H B M Smit; Marco J Koudijs; Isaac J Nijman; Emile E Voest; Pier Selenica; Britta Weigelt; Jorge S Reis-Filho; Elsken van der Wall; Edwin Cuppen; Paul J van Diest Journal: Endocr Relat Cancer Date: 2019-10 Impact factor: 5.678
Authors: Zhijing Tan; Jianhui Zhu; Paul M Stemmer; Liangliang Sun; Zhichang Yang; Kendall Schultz; Matthew J Gaffrey; Anthony J Cesnik; Xinpei Yi; Xiaohu Hao; Michael R Shortreed; Tujin Shi; David M Lubman Journal: J Proteome Res Date: 2020-02-27 Impact factor: 4.466